Skip to main content
Top
Published in: Diabetologia 2/2010

01-02-2010 | Article

Impaired wound healing in mouse models of diabetes is mediated by TNF-α dysregulation and associated with enhanced activation of forkhead box O1 (FOXO1)

Authors: M. F. Siqueira, J. Li, L. Chehab, T. Desta, T. Chino, N. Krothpali, Y. Behl, M. Alikhani, J. Yang, C. Braasch, D. T. Graves

Published in: Diabetologia | Issue 2/2010

Login to get access

Abstract

Aims/hypothesis

The role of TNF-α in impaired wound healing in diabetes was examined by focusing on fibroblasts.

Methods

Small excisional wounds were created in the db/db mice model of type 2 diabetes and normoglycaemic littermates, and in a streptozotocin-induced type 1 diabetes mouse model and control mice. Fibroblast apoptosis was measured by the TUNEL assay, proliferation by detection of proliferating cell nuclear antigen, and forkhead box O1 (FOXO1) activity by DNA binding and nuclear translocation. TNF-α was specifically inhibited by pegsunercept.

Results

Diabetic wounds had increased TNF-α, fibroblast apoptosis, caspase-3/7 activity and activation of the pro-apoptotic transcription factor FOXO1, and decreased proliferating cell nuclear antigen positive fibroblasts (p < 0.05). TNF-α inhibition improved healing in the diabetic mice and increased fibroblast density. This may be explained by a decrease in fibroblast apoptosis and increased proliferation when TNF-α was blocked (p < 0.05). Although decreased fibroblast proliferation and enhanced FOXO1 activity were investigated in type 2 diabetes, they may also be implicated in type 1 diabetes. In vitro, TNF-α enhanced mRNA levels of gene sets related to apoptosis and Akt and p53 but not mitochondrial or cell-cycle pathways. FOXO1 small interfering RNA reduced gene sets that regulate apoptosis, Akt, mitochondrial and cell-cycle pathways. TNF-α also increased genes involved in inflammation, cytokine, Toll-like receptor and nuclear factor-kB pathways, which were significantly reduced by FOXO1 knockdown.

Conclusions/interpretation

These studies indicate that TNF-α dysregulation in diabetic wounds impairs healing, which may involve enhanced fibroblast apoptosis and decreased proliferation. In vitro, TNF-α induced gene sets through FOXO1 that regulate a number of pathways that could influence inflammation and apoptosis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lioupis C (2005) Effects of diabetes mellitus on wound healing: an update. J Wound Care 14:84–86PubMed Lioupis C (2005) Effects of diabetes mellitus on wound healing: an update. J Wound Care 14:84–86PubMed
2.
go back to reference Claxton MJ, Armstrong DG, Boulton AJ (2002) Healing the diabetic wound and keeping it healed: modalities for the early 21st century. Curr Diab Rep 2:510–518CrossRefPubMed Claxton MJ, Armstrong DG, Boulton AJ (2002) Healing the diabetic wound and keeping it healed: modalities for the early 21st century. Curr Diab Rep 2:510–518CrossRefPubMed
3.
go back to reference Singh N, Armstrong DG, Lipsky BA (2005) Preventing foot ulcers in patients with diabetes. JAMA 293:217–228CrossRefPubMed Singh N, Armstrong DG, Lipsky BA (2005) Preventing foot ulcers in patients with diabetes. JAMA 293:217–228CrossRefPubMed
4.
5.
go back to reference Kane CD, Greenhalgh DG (2000) Expression and localization of p53 and bcl-2 in healing wounds in diabetic and nondiabetic mice. Wound Repair Regen 8:45–58CrossRefPubMed Kane CD, Greenhalgh DG (2000) Expression and localization of p53 and bcl-2 in healing wounds in diabetic and nondiabetic mice. Wound Repair Regen 8:45–58CrossRefPubMed
6.
go back to reference Pierce GF (2001) Inflammation in nonhealing diabetic wounds: the space–time continuum does matter. Am J Pathol 159:399–403PubMed Pierce GF (2001) Inflammation in nonhealing diabetic wounds: the space–time continuum does matter. Am J Pathol 159:399–403PubMed
7.
go back to reference Lobmann R, Ambrosch A, Schultz G, Waldmann K, Schiweck S, Lehnert H (2002) Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 45:1011–1016CrossRefPubMed Lobmann R, Ambrosch A, Schultz G, Waldmann K, Schiweck S, Lehnert H (2002) Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 45:1011–1016CrossRefPubMed
8.
go back to reference Trengove NJ, Stacey MC, MacAuley S et al (1999) Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen 7:442–452CrossRefPubMed Trengove NJ, Stacey MC, MacAuley S et al (1999) Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen 7:442–452CrossRefPubMed
9.
go back to reference Hehenberger K, Heilborn JD, Brismar K, Hansson A (1998) Inhibited proliferation of fibroblasts derived from chronic diabetic wounds and normal dermal fibroblasts treated with high glucose is associated with increased formation of l-lactate. Wound Repair Regen 6:135–141CrossRefPubMed Hehenberger K, Heilborn JD, Brismar K, Hansson A (1998) Inhibited proliferation of fibroblasts derived from chronic diabetic wounds and normal dermal fibroblasts treated with high glucose is associated with increased formation of l-lactate. Wound Repair Regen 6:135–141CrossRefPubMed
10.
go back to reference Wetzler C, Kampfer H, Stallmeyer B, Pfeilschifter J, Frank S (2000) Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol 115:245–253CrossRefPubMed Wetzler C, Kampfer H, Stallmeyer B, Pfeilschifter J, Frank S (2000) Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol 115:245–253CrossRefPubMed
11.
go back to reference Loots M, Lamme E, Zeegelaar J, Mekkes J, Bos J, Middelkoop E (1998) Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers vs acute wounds. J Invest Dermatol 111:850–857CrossRefPubMed Loots M, Lamme E, Zeegelaar J, Mekkes J, Bos J, Middelkoop E (1998) Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers vs acute wounds. J Invest Dermatol 111:850–857CrossRefPubMed
12.
go back to reference Komesu M, Tanga M, Buttros K, Nakao C (2004) Effects of acute diabetes on rat cutaneous wound healing. Pathophysiology 11:63–67CrossRefPubMed Komesu M, Tanga M, Buttros K, Nakao C (2004) Effects of acute diabetes on rat cutaneous wound healing. Pathophysiology 11:63–67CrossRefPubMed
13.
go back to reference Rai NK, Tripathi K, Sharma D, Shakla V (2005) Apoptosis: a basic physiologic process in wound healing. Int J Low Extrem Wounds 4:138–144CrossRefPubMed Rai NK, Tripathi K, Sharma D, Shakla V (2005) Apoptosis: a basic physiologic process in wound healing. Int J Low Extrem Wounds 4:138–144CrossRefPubMed
16.
go back to reference Darby I, Bisucci T, Hewitson T, MacLellan D (1997) Apoptosis is increased in a model of diabetes-impaired wound healing in genetically diabetic mice. Int J Biochem Cell Biol 29:191–200CrossRefPubMed Darby I, Bisucci T, Hewitson T, MacLellan D (1997) Apoptosis is increased in a model of diabetes-impaired wound healing in genetically diabetic mice. Int J Biochem Cell Biol 29:191–200CrossRefPubMed
17.
go back to reference Rai NK, Suryabhan, Ansari M, Kumar M, Shukla VK, Tripathi K (2005) Effect of glycaemic control on apoptosis in diabetic wounds. J Wound Care 14:277–281PubMed Rai NK, Suryabhan, Ansari M, Kumar M, Shukla VK, Tripathi K (2005) Effect of glycaemic control on apoptosis in diabetic wounds. J Wound Care 14:277–281PubMed
18.
go back to reference Desmouliere A, Redard M, Darby I, Gabbiani G (1995) Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 146:56–66PubMed Desmouliere A, Redard M, Darby I, Gabbiani G (1995) Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 146:56–66PubMed
19.
go back to reference Messadi DV, Le A, Berg S et al (1999) Expression of apoptosis-associated genes by human dermal scar fibroblasts. Wound Repair Regen 7:511–517CrossRefPubMed Messadi DV, Le A, Berg S et al (1999) Expression of apoptosis-associated genes by human dermal scar fibroblasts. Wound Repair Regen 7:511–517CrossRefPubMed
20.
go back to reference Ladin DA, Hou Z, Patel D et al (1998) p53 and apoptosis alterations in keloids and keloid fibroblasts. Wound Repair Regen 6:28–37CrossRefPubMed Ladin DA, Hou Z, Patel D et al (1998) p53 and apoptosis alterations in keloids and keloid fibroblasts. Wound Repair Regen 6:28–37CrossRefPubMed
21.
go back to reference Taylor PC (2001) Anti-TNF therapy for rheumatoid arthritis and other inflammatory diseases. Mol Biotechnol 19:153–168CrossRefPubMed Taylor PC (2001) Anti-TNF therapy for rheumatoid arthritis and other inflammatory diseases. Mol Biotechnol 19:153–168CrossRefPubMed
22.
go back to reference Klimiuk PA, Sierakowski S, Domyslawska I, Chwiecko J (2004) Effect of repeated infliximab therapy on serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with rheumatoid arthritis. J Rheumatol 31:238–242PubMed Klimiuk PA, Sierakowski S, Domyslawska I, Chwiecko J (2004) Effect of repeated infliximab therapy on serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with rheumatoid arthritis. J Rheumatol 31:238–242PubMed
23.
go back to reference Ardizzone S, Bianchi Porro G (2005) Biologic therapy for inflammatory bowel disease. Drugs 65:2253–2286CrossRefPubMed Ardizzone S, Bianchi Porro G (2005) Biologic therapy for inflammatory bowel disease. Drugs 65:2253–2286CrossRefPubMed
24.
go back to reference Graves DT, Liu R, Alikhani M, Al-Mashat H, Trackman PC (2006) Diabetes-enhanced inflammation and apoptosis—impact on periodontal pathology. J Dent Res 85:15–21CrossRefPubMed Graves DT, Liu R, Alikhani M, Al-Mashat H, Trackman PC (2006) Diabetes-enhanced inflammation and apoptosis—impact on periodontal pathology. J Dent Res 85:15–21CrossRefPubMed
25.
go back to reference Goova MT, Li J, Kislinger T et al (2001) Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol 159:513–525PubMed Goova MT, Li J, Kislinger T et al (2001) Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol 159:513–525PubMed
26.
go back to reference Buck M, Houglum K, Chojkier M (1996) Tumor necrosis factor inhibits collagen 1 gene expression and wound healing in a murine model of cachexia. Am J Pathol 149:195–204PubMed Buck M, Houglum K, Chojkier M (1996) Tumor necrosis factor inhibits collagen 1 gene expression and wound healing in a murine model of cachexia. Am J Pathol 149:195–204PubMed
27.
go back to reference Salomon GD, Kasid A, Cromack DT et al (1991) The local effects of cachectin/tumor necrosis factor on wound healing. Ann Surg 214:175–180CrossRefPubMed Salomon GD, Kasid A, Cromack DT et al (1991) The local effects of cachectin/tumor necrosis factor on wound healing. Ann Surg 214:175–180CrossRefPubMed
28.
go back to reference Moller DE (2000) Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab 11:212–217CrossRefPubMed Moller DE (2000) Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab 11:212–217CrossRefPubMed
29.
go back to reference Uno S, Imagawa A, Okita K et al (2007) Macrophages and dendritic cells infiltrating islets with or without beta cells produce tumour necrosis factor-alpha in patients with recent-onset type 1 diabetes. Diabetologia 50:596–601CrossRefPubMed Uno S, Imagawa A, Okita K et al (2007) Macrophages and dendritic cells infiltrating islets with or without beta cells produce tumour necrosis factor-alpha in patients with recent-onset type 1 diabetes. Diabetologia 50:596–601CrossRefPubMed
30.
go back to reference Behl Y, Krothapalli P, Desta T, Dipiazza A, Roy S, Graves DT (2008) Diabetes-enhanced tumor necrosis factor-alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy. Am J Pathol 172:1411–1418CrossRefPubMed Behl Y, Krothapalli P, Desta T, Dipiazza A, Roy S, Graves DT (2008) Diabetes-enhanced tumor necrosis factor-alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy. Am J Pathol 172:1411–1418CrossRefPubMed
31.
go back to reference Navarro-Gonzalez JF, Mora-Fernandez C (2008) The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 19:433–442CrossRefPubMed Navarro-Gonzalez JF, Mora-Fernandez C (2008) The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 19:433–442CrossRefPubMed
32.
go back to reference Brown D, Kao W, Greenhalgh D (1997) Apoptosis down-regulates inflammation under the advancing epithelial wound edge: delayed patterns in diabetes and improvement with topical growth factors. Surgery 121:372–380CrossRefPubMed Brown D, Kao W, Greenhalgh D (1997) Apoptosis down-regulates inflammation under the advancing epithelial wound edge: delayed patterns in diabetes and improvement with topical growth factors. Surgery 121:372–380CrossRefPubMed
33.
go back to reference Kayal RA, Tsatsas D, Bauer MA et al (2007) Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activity. J Bone Miner Res 22:560–568CrossRefPubMed Kayal RA, Tsatsas D, Bauer MA et al (2007) Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activity. J Bone Miner Res 22:560–568CrossRefPubMed
34.
go back to reference Graves D, Nooh N, Gillen T et al (2001) IL-1 plays a critical role in oral, but not dermal, wound healing. J Immunol 167:5316–5320PubMed Graves D, Nooh N, Gillen T et al (2001) IL-1 plays a critical role in oral, but not dermal, wound healing. J Immunol 167:5316–5320PubMed
35.
go back to reference Nooh N, Graves D (2003) Healing is delayed in oral compared to dermal excisional wounds. J Periodontol 74:242–246CrossRefPubMed Nooh N, Graves D (2003) Healing is delayed in oral compared to dermal excisional wounds. J Periodontol 74:242–246CrossRefPubMed
36.
go back to reference Davidson JM (1998) Wound repair. J Hand Ther 11:80–94 Davidson JM (1998) Wound repair. J Hand Ther 11:80–94
37.
go back to reference Furst DE, Fleischmann R, Kopp E et al (2005) A phase 2 dose-finding study of PEGylated recombinant methionyl human soluble tumor necrosis factor type I in patients with rheumatoid arthritis. J Rheumatol 32:2303–2310PubMed Furst DE, Fleischmann R, Kopp E et al (2005) A phase 2 dose-finding study of PEGylated recombinant methionyl human soluble tumor necrosis factor type I in patients with rheumatoid arthritis. J Rheumatol 32:2303–2310PubMed
38.
go back to reference Scallon B, Cai A, Solowski N et al (2002) Binding and functional comparisons of two types of tumor necrosis factor antagonists. J Pharmacol Exp Ther 301:418–426CrossRefPubMed Scallon B, Cai A, Solowski N et al (2002) Binding and functional comparisons of two types of tumor necrosis factor antagonists. J Pharmacol Exp Ther 301:418–426CrossRefPubMed
39.
go back to reference Kaymakcalan Z, Sakorafas P, Bose S et al (2009) Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor. Clin Immunol 131:308–316CrossRefPubMed Kaymakcalan Z, Sakorafas P, Bose S et al (2009) Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor. Clin Immunol 131:308–316CrossRefPubMed
40.
go back to reference Agnholt J, Dahlerup JF, Kaltoft K (2003) The effect of etanercept and infliximab on the production of tumour necrosis factor alpha, interferon-gamma and GM-CSF in in vivo activated intestinal T lymphocyte cultures. Cytokine 23:76–85CrossRefPubMed Agnholt J, Dahlerup JF, Kaltoft K (2003) The effect of etanercept and infliximab on the production of tumour necrosis factor alpha, interferon-gamma and GM-CSF in in vivo activated intestinal T lymphocyte cultures. Cytokine 23:76–85CrossRefPubMed
41.
go back to reference Kuroda K, Tajima S (2004) HSP47 is a useful marker for skin fibroblasts in formalin-fixed, paraffin-embedded tissue specimens. J Cutan Pathol 31:241–246CrossRefPubMed Kuroda K, Tajima S (2004) HSP47 is a useful marker for skin fibroblasts in formalin-fixed, paraffin-embedded tissue specimens. J Cutan Pathol 31:241–246CrossRefPubMed
42.
go back to reference Alikhani M, Alikhani Z, Graves DT (2005) FOXO1 functions as a master switch that regulates gene expression necessary for tumor necrosis factor-induced fibroblast apoptosis. J Biol Chem 280:12096–12102CrossRefPubMed Alikhani M, Alikhani Z, Graves DT (2005) FOXO1 functions as a master switch that regulates gene expression necessary for tumor necrosis factor-induced fibroblast apoptosis. J Biol Chem 280:12096–12102CrossRefPubMed
43.
go back to reference Subramanian A, Tamayo P, Mootha VK et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545–15550CrossRefPubMed Subramanian A, Tamayo P, Mootha VK et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545–15550CrossRefPubMed
44.
go back to reference Goren I, Muller E, Schiefelbein D et al (2007) Systemic anti-TNFalpha treatment restores diabetes-impaired skin repair in ob/ob mice by inactivation of macrophages. J Invest Dermatol 127:2259–2267CrossRefPubMed Goren I, Muller E, Schiefelbein D et al (2007) Systemic anti-TNFalpha treatment restores diabetes-impaired skin repair in ob/ob mice by inactivation of macrophages. J Invest Dermatol 127:2259–2267CrossRefPubMed
45.
go back to reference Mori R, Kondo T, Ohshima T, Ishida Y, Mukaida N (2002) Accelerated wound healing in tumor necrosis factor receptor p55-deficient mice with reduced leukocyte infiltration. FASEB J 16:963–974CrossRefPubMed Mori R, Kondo T, Ohshima T, Ishida Y, Mukaida N (2002) Accelerated wound healing in tumor necrosis factor receptor p55-deficient mice with reduced leukocyte infiltration. FASEB J 16:963–974CrossRefPubMed
46.
go back to reference Rapala K, Laato M, Niinikoski J et al (1991) Tumor necrosis factor alpha inhibits wound healing in the rat. Eur Surg Res 23:261–268CrossRefPubMed Rapala K, Laato M, Niinikoski J et al (1991) Tumor necrosis factor alpha inhibits wound healing in the rat. Eur Surg Res 23:261–268CrossRefPubMed
47.
go back to reference Regan MC, Kirk SJ, Hurson M, Sodeyama M, Wasserkrug HL, Barbul A (1993) Tumor necrosis factor-alpha inhibits in vivo collagen synthesis. Surgery 113:173–177PubMed Regan MC, Kirk SJ, Hurson M, Sodeyama M, Wasserkrug HL, Barbul A (1993) Tumor necrosis factor-alpha inhibits in vivo collagen synthesis. Surgery 113:173–177PubMed
48.
go back to reference Curtis RK, Oresic M, Vidal-Puig A (2005) Pathways to the analysis of microarray data. Trends Biotechnol 23:429–435 Curtis RK, Oresic M, Vidal-Puig A (2005) Pathways to the analysis of microarray data. Trends Biotechnol 23:429–435
49.
go back to reference Huang H, Regan K, Lou Z, Chen J, Tindall D (2006) CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage. Science 314:294–297CrossRefPubMed Huang H, Regan K, Lou Z, Chen J, Tindall D (2006) CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage. Science 314:294–297CrossRefPubMed
50.
go back to reference Al-Mashat HA, Kandru S, Liu R, Behl Y, Desta T, Graves DT (2006) Diabetes enhances mRNA levels of proapoptotic genes and caspase activity, which contribute to impaired healing. Diabetes 55:487–495CrossRefPubMed Al-Mashat HA, Kandru S, Liu R, Behl Y, Desta T, Graves DT (2006) Diabetes enhances mRNA levels of proapoptotic genes and caspase activity, which contribute to impaired healing. Diabetes 55:487–495CrossRefPubMed
Metadata
Title
Impaired wound healing in mouse models of diabetes is mediated by TNF-α dysregulation and associated with enhanced activation of forkhead box O1 (FOXO1)
Authors
M. F. Siqueira
J. Li
L. Chehab
T. Desta
T. Chino
N. Krothpali
Y. Behl
M. Alikhani
J. Yang
C. Braasch
D. T. Graves
Publication date
01-02-2010
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 2/2010
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1529-y

Other articles of this Issue 2/2010

Diabetologia 2/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.